questionText: To ask the Secretary of State for Health and Social Care, what recent assessment she has made of the adequacy of the global supply of (a) Methylphenidate, (b) Lisdexamfetamine, (c) Guanfacine and (d) other Attention Deficit Hyperactivity Disorder medicati
answerText: Shortages of medicines for attention deficit hyperactivity disorder (ADHD) including methylphenidate, lisdexamfetamine, and guanfacine have primarily been driven by regulatory issues at key manufacturing sites and capacity constraints at third party manuf...
heading: Attention Deficit Hyperactivity Disorder: Drugs